1-3411903-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_022114.4(PRDM16):c.1706C>T(p.Thr569Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000026 in 1,613,504 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T569T) has been classified as Likely benign.
Frequency
Consequence
NM_022114.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRDM16 | NM_022114.4 | c.1706C>T | p.Thr569Met | missense_variant | 9/17 | ENST00000270722.10 | NP_071397.3 | |
PRDM16 | NM_199454.3 | c.1706C>T | p.Thr569Met | missense_variant | 9/17 | NP_955533.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRDM16 | ENST00000270722.10 | c.1706C>T | p.Thr569Met | missense_variant | 9/17 | 1 | NM_022114.4 | ENSP00000270722.5 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152164Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000363 AC: 9AN: 247932Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134726
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461340Hom.: 0 Cov.: 37 AF XY: 0.0000165 AC XY: 12AN XY: 726948
GnomAD4 genome AF: 0.000131 AC: 20AN: 152164Hom.: 0 Cov.: 33 AF XY: 0.000135 AC XY: 10AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 01, 2016 | Variant classified as Uncertain Significance - Favor Benign. The p.Thr569Met var iant in PRDM16 has not been previously reported in individuals with cardiomyopat hy. This variant has been identified in 5/9438 African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs200647136) . Threonine (Thr) at position 569 is not conserved in mammals or evolutionarily distant species, raising the possibility that a change at this position may be t olerated. Additional computational prediction tools suggest that the p.Thr569Met variant may not impact the protein, though this information is not predictive e nough to rule out pathogenicity. In summary, while the clinical significance of the p.Thr569Met variant is uncertain, these data suggest that it is more likely to be benign. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 05, 2023 | The c.1706C>T (p.T569M) alteration is located in exon 9 (coding exon 9) of the PRDM16 gene. This alteration results from a C to T substitution at nucleotide position 1706, causing the threonine (T) at amino acid position 569 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 31, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Left ventricular noncompaction 8 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 17, 2023 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 569 of the PRDM16 protein (p.Thr569Met). This variant is present in population databases (rs200647136, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with PRDM16-related conditions. ClinVar contains an entry for this variant (Variation ID: 426420). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at